home > ict > spring 2021 > clinical trials in 3d decentralised, data science, and digital transformation
International Clinical Trials

Clinical Trials in 3D Decentralised, Data Science, and Digital Transformation

A new era of clinical research has begun where the old ways of recruiting, conducting studies, and analysing data are simply no longer viable. As sponsors evaluate new clinical technologies and assess their existing systems, the emphasis must now be on those solutions that optimise clinical trial data workflows by bringing the tech to data. Specifically, the new world needs to easily handle disparate and unstructured data, reduce the burden on site staff, and provide a holistic view of the trial data with immediate visibility to give total control from Phase I to IV.

Halt and Catch Fire

2020 was likely the most challenging year our industry has ever faced. After an enforced pause, we have begun to realise that now is the time to address the many challenges plaguing clinical trial data, including the pain around aggregating and integrating disparate data in complex trials, the perpetual data lag from capture to analysis, canned two-dimensional and poor-quality visualisations, the inability of study teams to act in a timely manner, to gain deeper insights, and operationalise the data.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the Author

Temitope (Tope) Keyes has 22 years of clinical R&D experience, which began on the sponsor side, with the majority of that primarily in the eClinical solutions space. She has a passion for technology and its ability to advance vital clinical research and successful trial execution. Her experience includes pre-clinical purchasing and clinical outsourcing roles at AstraZeneca and Sanofi, followed by almost 15 years in business development with the likes of ERT, Synteract, Datatrak, and Axiom Real-Time Metrics. Tope joined Cmed Technology in 2020, where she drives the sales and marketing for the encapsia clinical technology platform.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Five methods for reducing pharmaceutical cargo theft

In North America, five percent of cargo thefts that occurred in 2020 were pharmaceutical products and 74 percent of all cargo theft occurred in transit, according to the BSI and TT Club Cargo Theft Report 2021. In the US and Canada, the biggest threat comes when containers or trailers are parked at insecure locations, as those were the most exploited vulnerabilities last year. Market dynamics also changed due to Covid-19, as demonstrated by the fact that the theft of stolen cargo in the form of medical supplies such as PPE, increased by more than 5,000 per cent in 2020, compared to 2019.
More info >>

White Papers



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement